Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jun;37(6):1168-1174.
doi: 10.1111/jdv.18925. Epub 2023 Feb 13.

Tapinarof for psoriasis and atopic dermatitis: 15 years of clinical research

R Bissonnette  1 , E Saint-Cyr Proulx  1 , C Jack  1 , C Maari  1
Affiliations
Review

Tapinarof for psoriasis and atopic dermatitis: 15 years of clinical research

R Bissonnette et al. J Eur Acad Dermatol Venereol. 2023 Jun.

Abstract

Tapinarof is a topical, aryl-hydrocarbon receptor agonist that has recently received FDA-approval for the treatment of psoriasis. This novel therapeutic has also been shown to be effective for atopic dermatitis and is currently in phase 3 for this indication. Beyond good efficacy and fast onset of action in patients with psoriasis, the clinical response to tapinarof is notable for durable remission or near remission, maintained for an average of 130 days beyond treatment discontinuation in patients with psoriasis in phase 3 studies. Tapinarof is usually well tolerated but can induce a follicular inflammatory reaction and dermatitis in some patients. This narrative review covers the historical development of this molecule, safety and efficacy data from clinical trials conducted with various topical formulations, and practical considerations derived from our 15 years of clinical trial experience with the drug.

PubMed Disclaimer

Comment in

References

REFERENCES

    1. Li J, Chen G, Wu H, Webster JM. Identification of two pigments and a hydroxystilbene antibiotic from Photorhabdus luminescens. Appl Environ Microbiol. 1995;61(12):4329-33.
    1. Hu K, Webster JM. Antibiotic production in relation to bacterial growth and nematode development in Photorhabdus-Heterorhabditis infected Galleria mellonella larvae. FEMS Microbiol Lett. 2000;189(2):219-23.
    1. Welichem Biotech Inc., Inventor. Polyhydroxystilbenes and stilbene oxides as antisoriatic agents and protein kinase inhibitors. [cited 2001 Jun 14]. US patent WO2001042231.
    1. Bissonnette R, Bolduc C, Maari C, Nigen S, Webster JM, Tang L, et al. Efficacy and safety of topical WBI-1001 in patients with mild to moderate psoriasis: results from a randomized double-blind placebo-controlled, phase II trial. J Eur Acad Dermatol Venereol. 2012;26(12):1516-21.
    1. Bissonnette R, Chen G, Bolduc C, Maari C, Lyle M, Tang L, et al. Efficacy and safety of topical WBI-1001 in the treatment of atopic dermatitis: results from a phase 2A, randomized, placebo-controlled clinical trial. Arch Dermatol. 2010;146(4):446-9.

MeSH terms

LinkOut - more resources